Latest Reports
Israel Probiotics Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Ingredient (Bacteria (Lactobacilli, Bifidobacterium, Streptococcus Thermophilus), Yeast (Saccharomyces, Boulardii, Others)), By Form (Liquid, Dry), By Application (Functional Food And Beverages, Dietary Supplements, Animal Feed), And By End-User (Human, Animal) - Forecasts From 2022 To 2027
The Israel probiotics market is anticipated to expand at a CAGR of 5.60% over the course of the forecast period, from US$0.17 billion in 2020 to a total market value of US$0.249 billion in 2027. Live microorganisms known as probiotics are ...
Japan Probiotics Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Lactobacillus, Streptococcus, Bifidobacterium, Spore Formers, Others), By Form (Liquid, Dry), By Application (Functional Food And Beverages, Dietary Supplements, Animal Feed), And By End-User (Human, Animal) - Forecasts From 2022 To 2027
Japan’s Probiotics market is projected to grow at a CAGR of 7.57% to reach US$12.123 billion by 2027, from US$7.274 billion in 2020. Probiotics are living microorganisms that have health benefits when they are either consumed or appl...
Germany Flu Diagnostic and Treatment Market Size, Share, Opportunities, And Trends By Type Of Flu (Type A, Type B), By Offering (Diagnostics (Rapid Influenza Diagnostic Test, Rapid Molecular Assay, Others), Therapeutics), By Age Group (0-14 Years, 15-64 Years, >=65 Years), And By End-User (Hospital Laboratory, Outpatient Clinic, Reference Laboratory) - Forecasts From 2022 To 2027
The Germany flu diagnostic and treatment market is projected to grow at a CAGR of 14.13% throughout the forecast period to reach US$6,653.487 million in 2027, from US$2,638.271 million in 2020. The market for flu diagnostics and treatment ...
Argentina Magnetic Resonance Imaging (MRI) Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type (Closed, Open), By End-Use (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others), By Field Strength (Low Field Strength, Mid Field Strength, High Field Strength), And By Application (Cerebral, Musculoskeletal, Abdominal, Cardiac, Breast, Vascular, Others) - Forecasts From 2022 To 2027
The Argentina magnetic resonance imaging (MRI) market is expected to grow at a CAGR of 2.52% over the forecast period to reach a market size of US$47.497 million in 2027, from US$39.903 million in 2020. Magnetic Resonance Imaging is a techn...
Indonesia Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals) And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Indonesia antirheumatic drugs market was valued at US$3,543.837 million in 2020. The market is projected to grow at a CAGR of 3.00% to attain a value of US$4,359.458 million by 2027. The market for antirheumatic drugs in Indonesia is proj...
China Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals) And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
China antirheumatic drugs market was valued at US$19.081 billion in 2020. The market is projected to grow at a CAGR of 3.73% to attain a value of US$24.654 billion by 2027. A growing number of patients suffering from arthritis in China is ...
Asia Pacific (APAC) Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals), By Type (Prescription, Over-the-counter (OTC)), And By Country - Forecasts From 2022 To 2027
Asia Pacific (APAC) antirheumatic drugs market was evaluated at US$48.438 billion for the year 2020, growing at a CAGR of 3.37% reaching the market size of US$61.086 billion by the year 2027. The rapidly growing number of patients sufferin...
Europe Anti-Rheumatic Drug Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals), By Type (Prescription, Over-the-counter (OTC)), And By Country - Forecasts From 2022 To 2027
European antirheumatic drugs market is estimated grow with a CAGR of 2.87% over the forecast period to attain a market size of US$51,553.83 million in 2027, from US$42,299.989 million in 2020. The antirheumatic drugs market in the European...
Myanmar Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals) And By Type (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Myanmar antirheumatic drugs market was valued at US$718.219 million in 2020 and is projected to grow during the forecast period. The significant prevalence of overweight and obesity in Myanmar is causing a rise in the number of people suf...
Nigeria Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities And Trends By Type of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Type of Molecule (Pharmaceuticals, Biopharmaceuticals), And By Type (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Nigeria antirheumatic drugs market was valued at US$822.216 million in 2020 and is forecasted to grow in the coming years as well. The primary factors driving the demand for numerous antirheumatic drugs in the country include the rising p...
Japan Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
Japan’s antirheumatic drug market was valued at US$15,757.740 million in 2020. The market is projected to grow at a CAGR of 3.99% to attain a value of US$20,723.660 million by 2027. The market’s growth is being majorly driven by...
Mexico Anti-Rheumatic Drug Market Size, Share, COVID-19 Impact, Opportunities, And Trends By Type Of Disease (Osteoarthritis, Rheumatoid Arthritis, Gout, Lupus, Others), By Drug Class (Disease-modifying Anti-Rheumatic Drugs (DMARDs), Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, JAK Inhibitor, Others), And By Sales Channel (Prescription, Over-the-counter (OTC)) - Forecasts From 2022 To 2027
The Mexican antirheumatic drugs market was valued at US$6,326.779 million in 2020. The market is projected to grow at a CAGR of 2.12% to attain a value of US$7,327.540 million by 2027. The rising Mexican population suffering from arthritis ...
Related Intelligence Hubs
Explore interconnected markets and cross-industry research.